| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ede93eb85669c993682250d748f412f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-482
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64 |
| filingDate |
2016-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a324c1a69b47d0caf4d0b4d14522ebfb |
| publicationDate |
2018-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2018023071-A1 |
| titleOfInvention |
Peptides derived from human pcsk9 catalytic domain and uses thereof for promoting ldl-r activity |
| abstract |
The present invention provides compositions comprising an isolated or purified therapeutically effective hPCSK9 polypeptide derived from the hPCSK9 catalytic domain, and their use in methods of treating hypercholesterolemia. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022089640-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11427616-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020005869-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020009805-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11530244-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11484565-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11306125-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11505575-B2 |
| priorityDate |
2015-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |